Search Results - Philippe Kostrewa
- Showing 1 - 3 results of 3
-
1
Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia by Andreas Burchert, Martin C. Müller, Philippe Kostrewa, Philipp Erben, Tilman Bostel, Simone Liebler, Rüdiger Hehlmann, Andreas Neubauer, Andreas Hochhaus
Published 2010Artigo -
2
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia by Andreas Burchert, Susanne Saußele, Ekkehard Eigendorff, Martin C. Müller, Kristina Sohlbach, Sabrina Inselmann, Christin Schütz, Stephan Metzelder, Janine M. Ziermann, Philippe Kostrewa, Joerg Hoffmann, Rüdiger Hehlmann, Andreas Neubauer, Andreas Hochhaus
Published 2015Artigo -
3
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AG... by Boris Böll, Enrico Schalk, Dieter Buchheidt, Justin Hasenkamp, Michael Kiehl, Til R. Kiderlen, Matthias Kochanek, Michael Koldehoff, Philippe Kostrewa, Annika Y. Claßen, Sibylle C. Mellinghoff, Bernd Metzner, Olaf Penack, Markus Ruhnke, Maria J. G. T. Vehreschild, Florian Weißinger, Hans‐Heinrich Wolf, Meinolf Karthaus, Marcus Hentrich
Published 2020Revisão
Search Tools:
Related Subjects
Internal medicine
Medicine
Oncology
Alpha interferon
Discontinuation
Gastroenterology
Imatinib
Imatinib mesylate
Immunology
Interferon
Interferon alfa
Myeloid leukemia
Adverse effect
Cancer
Catheter
Central venous catheter
Chronic myelogenous leukemia
Civil engineering
Engineering
Grading (engineering)
Guideline
Hematology
Intensive care medicine
Law
Leukemia
MEDLINE
Pathology
Political science
Surgery
Tolerability